People: POZEN Inc. (POZN.O)

POZN.O on Consolidated Issue listed on NASDAQ Global Market

5.54USD
11:03am EST
Price Change (% chg)

$-0.20 (-3.48%)
Prev Close
$5.74
Open
$5.71
Day's High
$5.80
Day's Low
$5.54
Volume
4,045
Avg. Vol
71,011
52-wk High
$8.42
52-wk Low
$4.50

view people for:

Orlemans, Everardus 

Brief Biography

Mr. Everardus Orlemans , Ph.D. is Senior Vice President, Product Development of POZEN Inc. since January 2009. He joined POZEN in November 2005 as Vice President, Clinical Research and was promoted to Senior Vice President, Product Development in January 2009. Dr. Orlemans began his professional career with Organon NV, a pharmaceutical company based in the Netherlands, before transferring to its U.S. subsidiary, Organon Pharmaceuticals USA, Inc., where his most recent position was Executive Director of the Clinical Development Unit. Dr. Orlemans was an employee of Organon NV and/or its U.S. Subsidiary from October 1988 to March 2005. He received a M.S. in Chemistry from Catholic University of Nijmegen in the Netherlands and his Ph.D. degree from the University of Twente, also located in the Netherlands.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Excercisable -- --
Unexercisable -- --
Excercised -- --
Name Fiscal Year Total
Plachetka, John 2,244,440
Hodges, William 1,053,190
Cermak, Elizabeth --
Thomas, Gilda 601,995
Orlemans, Everardus --
Barnhardt, John 623,095
As Of 30 Dec 2008
view people for: